- Mithra grants a license to Farmitalia for commercialization of its vaginal contraceptive ring in Italy
- Italy is the third largest worldwide contraceptive ring market with nearly 2 million vaginal rings sold per year
- Mithra CDMO will launch the production of nearly 20,000 rings per month for the Italian market in the coming weeks
Liege, Belgium, 21 January 2020 – 7:30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces that it has entered into a license and supply agreement with Farmitalia for the commercialization of its hormonal contraceptive ring Myring™ in Italy.